A
$ Value
$0
Shares
75,000
Price
$0
Filed
Oct 8
Insider
Name
Winton Matthew
Title
Chief Commercial and Business
CIK
0001971400
Roles
Officer
Transaction Details
Transaction Date
2025-10-06
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
75,000
Footnotes
Shares granted as an inducement award material to Dr. Winton's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025.
Filing Info
Winton Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
| 2025-11-18 | CRVO | ▲ | $12K |
| 2025-11-17 | CRVO | ▲ | $30K |
| 2025-11-14 | CRVO | ▲ | $76K ★ |
| 2025-10-06 | CRVO | A | $0 |
| 2025-07-01 | INZY | U | $87K |
| 2025-07-01 | INZY | D | — |
| 2025-07-01 | INZY | D | — |
| 2025-06-25 | INZY | A | $11K |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
| Gregoire Sylvie | — | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |